Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Net Cash Flow (2020 - 2025)

Journey Medical's Net Cash Flow history spans 6 years, with the latest figure at -$858000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow fell 106.68% year-over-year to -$858000.0, compared with a TTM value of $3.8 million through Dec 2025, down 51.88%, and an annual FY2025 reading of $3.8 million, up 153.06% over the prior year.
  • Net Cash Flow for Q4 2025 was -$858000.0 at Journey Medical, down from $4.7 million in the prior quarter.
  • The five-year high for Net Cash Flow was $27.4 million in Q4 2021, with the low at -$9.1 million in Q2 2023.
  • Average Net Cash Flow over 5 years is $2.0 million, with a median of -$817500.0 recorded in 2025.
  • Year-over-year, Net Cash Flow surged 464.32% in 2021 and then tumbled 435.86% in 2025.
  • Tracing DERM's Net Cash Flow over 5 years: stood at $27.4 million in 2021, then tumbled by 110.54% to -$2.9 million in 2022, then soared by 193.14% to $2.7 million in 2023, then surged by 377.47% to $12.8 million in 2024, then crashed by 106.68% to -$858000.0 in 2025.
  • Per Business Quant, the three most recent readings for DERM's Net Cash Flow are -$858000.0 (Q4 2025), $4.7 million (Q3 2025), and -$777000.0 (Q2 2025).